These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 38856041)

  • 1. Mechanoimmunology in the solid tumor microenvironment.
    Golo M; Newman PLH; Kempe D; Biro M
    Biochem Soc Trans; 2024 Jun; 52(3):1489-1502. PubMed ID: 38856041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The solid tumor microenvironment-Breaking the barrier for T cells: How the solid tumor microenvironment influences T cells: How the solid tumor microenvironment influences T cells.
    Simsek H; Klotzsch E
    Bioessays; 2022 Jun; 44(6):e2100285. PubMed ID: 35393714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hijacked Immune Cells in the Tumor Microenvironment: Molecular Mechanisms of Immunosuppression and Cues to Improve T Cell-Based Immunotherapy of Solid Tumors.
    Balta E; Wabnitz GH; Samstag Y
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crosstalk between T lymphocyte and extracellular matrix in tumor microenvironment.
    Lv D; Fei Y; Chen H; Wang J; Han W; Cui B; Feng Y; Zhang P; Chen J
    Front Immunol; 2024; 15():1340702. PubMed ID: 38690275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
    Dzobo K
    OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding and improving cellular immunotherapies against cancer: From cell-manufacturing to tumor-immune models.
    Ringquist R; Ghoshal D; Jain R; Roy K
    Adv Drug Deliv Rev; 2021 Dec; 179():114003. PubMed ID: 34653533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies.
    Petitprez F; Meylan M; de Reyniès A; Sautès-Fridman C; Fridman WH
    Front Immunol; 2020; 11():784. PubMed ID: 32457745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor microenvironment and CAR-T cell immunotherapy in B-cell lymphoma.
    Cai F; Zhang J; Gao H; Shen H
    Eur J Haematol; 2024 Feb; 112(2):223-235. PubMed ID: 37706523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in CAR-T Cell Genetic Engineering Strategies to Overcome Hurdles in Solid Tumors Treatment.
    Andrea AE; Chiron A; Mallah S; Bessoles S; Sarrabayrouse G; Hacein-Bey-Abina S
    Front Immunol; 2022; 13():830292. PubMed ID: 35211124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy guided precision medicine in solid tumors.
    Mehrotra S; Kupani M; Kaur J; Kaur J; Pandey RK
    Adv Protein Chem Struct Biol; 2024; 140():249-292. PubMed ID: 38762271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling the tumor microenvironment: Insights into cancer metastasis and therapeutic strategies.
    El-Tanani M; Rabbani SA; Babiker R; Rangraze I; Kapre S; Palakurthi SS; Alnuqaydan AM; Aljabali AA; Rizzo M; El-Tanani Y; Tambuwala MM
    Cancer Lett; 2024 Jun; 591():216894. PubMed ID: 38626856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cell surface proteoglycans in cancer immunotherapy.
    Espinoza-Sánchez NA; Götte M
    Semin Cancer Biol; 2020 May; 62():48-67. PubMed ID: 31336150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obstacles to T cell migration in the tumor microenvironment.
    Nicolas-Boluda A; Donnadieu E
    Comp Immunol Microbiol Infect Dis; 2019 Apr; 63():22-30. PubMed ID: 30961814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance.
    Khalaf K; Hana D; Chou JT; Singh C; Mackiewicz A; Kaczmarek M
    Front Immunol; 2021; 12():656364. PubMed ID: 34122412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unlocking the potential of the tumor microenvironment for cancer therapy.
    Tufail M
    Pathol Res Pract; 2023 Nov; 251():154846. PubMed ID: 37837860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers.
    Mushtaq MU; Papadas A; Pagenkopf A; Flietner E; Morrow Z; Chaudhary SG; Asimakopoulos F
    J Immunother Cancer; 2018 Jul; 6(1):65. PubMed ID: 29970158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tumor microenvironment as a metabolic barrier to effector T cells and immunotherapy.
    Lim AR; Rathmell WK; Rathmell JC
    Elife; 2020 May; 9():. PubMed ID: 32367803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Roles of CD38 and CD157 in the Solid Tumor Microenvironment and Cancer Immunotherapy.
    Wo YJ; Gan ASP; Lim X; Tay ISY; Lim S; Lim JCT; Yeong JPS
    Cells; 2019 Dec; 9(1):. PubMed ID: 31861847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of tumor immunity and immunotherapy by the tumor collagen extracellular matrix.
    Flies DB; Langermann S; Jensen C; Karsdal MA; Willumsen N
    Front Immunol; 2023; 14():1199513. PubMed ID: 37662958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulating tumor physical microenvironment for fueling CAR-T cell therapy.
    Luo Z; Yao X; Li M; Fang D; Fei Y; Cheng Z; Xu Y; Zhu B
    Adv Drug Deliv Rev; 2022 Jun; 185():114301. PubMed ID: 35439570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.